I'm not a basher, not at all. Just doing some DD on HEB before I invest.
There just seems to be way to many negatives currently for me to invest in HEB. . just looking for something positive that is not only going to generate revenue but increase shareholder value.. which is why we are here isn't it?
That's not stretch. I checked the FDA website and it said the following:
"If the product's sale in the United States does not violate the Act, and the same product is intended for export for the same approved use and is accompanied closely by the FDA-approved labeling (if FDA labeling approval is required), FDA may consider the product to be sold or offered for sale in the United States. Nonetheless, under these circumstances, FDA would consider the product to be in compliance with the Act such that it would not have to meet the criteria of section 801(e)(1) of the Act to be exported."
So, Ampligen is for sale in the US for compassionate use, therefore, it can be exported for the same use.
So Jonj, how is HEB going to make this Ampligen for all these export sales?
Good JOB!!! you made a very smart investment!
Carter would like to thank you as well, his take is 5% and he calls it a "bonus". You on the other hand, have to wait for the stock to move up 5% to make the money you just paid Carter!!!
Very smart move Ewan!!
Let's just hope that Alferon for genital warts starts flying off the shelf some day when HEB can actually MFG it!!!
And why would they do that? .23 cent stock, a quarter of a billion shares outstanding and climbing daily ZERO sales, Carter takes A LOT of cash out the company because.. well he thinks he deserves it.
Ampligen cures Ebola in mice.
Alferon is a second line treatment for genital warts and COULD be used only after all other options have failed, so it's tough to hang your hat on that really turning out to be anything. It's been approved in Argentina for the same indication for 3 to 4 years now. Zero sales have been reported!!
Not sure why a "fund" would invest in 40 year old no revenue HEB. Wouldn't they just do a private placement of stock? That way they wouldn't have to pay Maxim 4% and then Carter, bless his heart, can take his 5% bonus?
That's awesome! I can't wait to see the sales numbers posted next quarter for the all the CFS patients in Australia and New Zealand!!!
My prediction? ZERO DOLLARS
What are your sales projections for next quarter?
Is Carter going to take 5% of the sales as a bonus from exports as well?
It's because Carter needs a bonus for his summer travels! He skims 5% right off the top of stock sales and takes it in cash!
Read all about it in the 10k filed with the SEC! I can't make this stuff up... it's just hilarious!
What a great CEO!!!
Easy 100 million in sales just off those 2 alone!!!!
Jonj, I think you analyst may have been right!!
Is this for the Ebola stricken mice? If so, this could be BIG NEWS!!! No one wants mice that have ebola running around!
ZMAP has been given fast track here in the US for Ebola in humans! I'm sure the EU will follow suit!
HEB should use this "surrogate endpoint" when it completes the next phase 3 study!
HEB already has 2 CRL's, one of which was under when fdasia was already law.
Carter should meet with the FDA to discuss using this "surrogate endpoint" in the next trial!
Wow, that's not good!
Was it in mice by chance? If it was, HEB has the CURE!! AMPLIGEN!!! It cures Ebola in mice!!
If it was humans, ZMAP is where the GOVT placed it's bet, it's got fast track status and has cured 2 humans!.
No no.. you have it backwards.
Carter is getting rich off shareholders!
Million dollar salary, 5% bonus from the sale of newly issued stock, having the company pay for a vacation home. Carter is living large on the backs of shareholders! I mean, really, HEB hasn't had any significant revenue in 20 years!
"I can wait for years"
I don't know if that is such a good thing, Dr Carter is in his late 70's.
"tell us something about any of the programs...."
Here are a couple of the bonus programs!
Carter and Equels each take a 5% bonus from the newly issued stock they sell through Maxim. Last quarter they sold 21 MILLION SHARES and each got a BONUS of over $230,000!!!
Carter also had HEB paying for his Vacation Home! 10k a month for a least 2 years!
All this from a non revenue company! Can't ask for a better CEO than that!
"I'm loading up... and riding it down"
You are a smart investor! Ride that wave down! It's only money right!
Besides, Carter has MILLIONS of shares to sell At The Market through Maxim! He sold 21 million last quarter! Carter also takes a 5% bonus from the sale of stock to put in his pocket!
Carter has one sweet gig going! Just keep buying! Carter has $75 million dollars worth of shares to unload!
" Just keep buying on the way down... That's how you make big money with Heb"
That is some smart thinking. Look at HEB's chart, it just keeps going south! Think how many shares you can buy at a penny!!
Just keep buying HEB SHARES, that is where smart money is.
"Nobel Prize Winner For years worked with Ampligen Why is that?"
Not sure but why is it then that the only proven use for Ampligen is curing Ebola in Mice? I'm sure the mice are happy, but it really doesn't mean much in sales.
Wow, that's cool!
Not sure what the market is for other "drugs" in this category. I do know that Avonex and CinnoVex, which are the synthetic Interferon, sales have been declining at a double digit rate.
Also, off label use isn't covered by insurance plans so whoever wants Alferon for off label is going to have to pay out of pocket.
The mouse population is very excited today as any mouse who has Ebola will now know there is a treatment available to them that has shown to cure them of this deadly disease. It's called Ampligen and it has only been proven to work in mice with ebola.
For Human with ebola, our GOVT has fast tracked Zmap which has cured 2 humans.
But the GOVT fast tracked Zmap instead. I'm guessing because ZMAP was proven and cured 2 humans.
If there is huge Ebola outbreak in the mouse population, I'm sure Ampligen will be the first drug they look at!